Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.73 - $3.0 $1,476 - $6,069
-2,023 Reduced 21.56%
7,359 $16,000
Q4 2023

Feb 13, 2024

SELL
$0.48 - $0.74 $244 - $377
-510 Reduced 5.16%
9,382 $6,000
Q3 2023

Nov 14, 2023

SELL
$0.72 - $0.9 $1,891 - $2,364
-2,627 Reduced 20.98%
9,892 $7,000
Q2 2023

Aug 14, 2023

BUY
$0.49 - $0.79 $4,446 - $7,168
9,074 Added 263.4%
12,519 $9,000
Q1 2023

May 09, 2023

SELL
$0.56 - $1.24 $3,314 - $7,339
-5,919 Reduced 63.21%
3,445 $3,000
Q4 2022

Feb 10, 2023

BUY
$0.83 - $2.26 $511 - $1,392
616 Added 7.04%
9,364 $10,000
Q3 2022

Nov 10, 2022

BUY
$1.93 - $3.14 $8,086 - $13,156
4,190 Added 91.93%
8,748 $19,000
Q2 2022

Aug 15, 2022

SELL
$1.69 - $3.26 $1,750 - $3,377
-1,036 Reduced 18.52%
4,558 $9,000
Q1 2022

May 12, 2022

BUY
$2.99 - $4.19 $6,332 - $8,874
2,118 Added 60.93%
5,594 $18,000
Q4 2021

Feb 14, 2022

BUY
$3.77 - $6.99 $13,104 - $24,297
3,476 New
3,476 $13,000
Q3 2021

Nov 15, 2021

SELL
$4.84 - $6.91 $803 - $1,147
-166 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$5.11 - $7.64 $12,131 - $18,137
-2,374 Reduced 93.46%
166 $1,000
Q1 2021

May 17, 2021

SELL
$5.03 - $10.5 $19,959 - $41,664
-3,968 Reduced 60.97%
2,540 $18,000
Q4 2020

Feb 16, 2021

BUY
$3.48 - $6.58 $22,647 - $42,822
6,508 New
6,508 $35,000
Q3 2020

Nov 16, 2020

SELL
$2.78 - $26.5 $10,500 - $100,090
-3,777 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$2.34 - $3.53 $226 - $342
-97 Reduced 2.5%
3,777 $11,000
Q1 2020

May 15, 2020

SELL
$2.3 - $5.5 $5,099 - $12,193
-2,217 Reduced 36.4%
3,874 $10,000
Q4 2019

Feb 07, 2020

BUY
$3.0 - $5.0 $17,502 - $29,170
5,834 Added 2270.04%
6,091 $20,000
Q3 2019

Nov 05, 2019

SELL
$3.31 - $5.6 $11,240 - $19,017
-3,396 Reduced 92.96%
257 $1,000
Q2 2019

Aug 13, 2019

BUY
$5.28 - $8.2 $6,526 - $10,135
1,236 Added 51.14%
3,653 $21,000
Q1 2019

May 14, 2019

SELL
$5.84 - $12.02 $33,585 - $69,127
-5,751 Reduced 70.41%
2,417 $19,000
Q4 2018

Feb 14, 2019

BUY
$6.32 - $19.44 $51,621 - $158,785
8,168 New
8,168 $67,000

Others Institutions Holding EQ

About Equillium, Inc.


  • Ticker EQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,352,100
  • Market Cap $47.1M
  • Description
  • Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...
More about EQ
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.